Stock & Company Details
InMed Pharmaceuticals Inc $INM
Price:
N/A
N/A
5.5M
$8.8M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.56
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
INM technical indicators
Latest InMed Pharmaceuticals Inc (INM) indicator readings as of 2026-10-29.
INM's 14-day RSI is 74.8, in overbought territory. At $1.63 it is trading 35.4% above its 200-day moving average of $1.20, and above its 50-day average of $1.38. Price sits above the upper Bollinger Band ($1.18 to $1.61). ADX reads 40.2, indicating a trending market.
Overview
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
Finance Bot
Ask your questions
Start by typing a question below.
